
Uniphos Enterprises is trading down 1.68% at ₹108.69. With a market cap of ₹765 Cr, it trades at a P/E of 36.91. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Uniphos Enterprises is trading down 1.68% at ₹108.69. With a market cap of ₹765 Cr, it trades at a P/E of 36.91. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Twelve years of multiples investors have paid for Uniphos Enterprises Limited, framed against the sector median so the premium or discount is obvious at a glance.
Uniphos Enterprises Limited trades at a P/E of 36.91× and P/B of 0.31×.
Auto-detected classical chart patterns for Uniphos Enterprises Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Twelve years of audited numbers for Uniphos Enterprises Limited, switchable between annual and quarterly views, consolidated or standalone.
Uniphos Enterprises Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹765 Cr and reported EPS of ₹2.98.
Disclosed business segments at Uniphos Enterprises with their share of revenue and profit, switchable between consolidated and standalone reporting.
Uniphos Enterprises discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Our AI distills the core fundamental drivers supporting Uniphos Enterprises Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Uniphos Enterprises Limited's investment case rests on 9 positive markers and 9 flagged concerns drawn from the latest reported filings.
Promoter holding is robust at 73.8%, indicating strong management confidence.
Zero debt-to-equity ratio (0.00) provides significant financial stability.
Stock trades below book value (0.39 P/B), potentially indicating an undervalued asset.
Substantial quarterly sales growth of 93.40% signals positive revenue momentum.
Increasing FII holding (15.71%) suggests growing external investor interest.
Reported negative quarterly profit after tax of -0.74 Cr.
Extremely low ROCE (0.06%) and ROE (0.01%) indicate poor capital returns.
Quarterly profit after tax declined drastically by -393.00%.
Negative EPS (-0.0382) reflects unprofitable operations, unattractive for investors.
Negative operating profit margin (-4.05%) highlights significant operational inefficiencies.
Trim if P/E re-rates above 48. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Income thesis breaks if the dividend is cut or yield falls below 0.23%.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Uniphos Enterprises Limited is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Uniphos Enterprises Limited — derived from the live tape, not yesterday's close.
Uniphos Enterprises Limited last traded at ₹108.69 with an intraday range of ₹107–₹113.5 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 125.46 | +16.77 | +15.43% |
| R3 | 118.96 | +10.27 | +9.45% |
| R2 | 116.23 | +7.54 | +6.94% |
| R1 | 112.46 | +3.77 | +3.47% |
| PIVOT | 109.73 | 1.04 | 0.96% |
| CURRENT | 108.69 | — | — |
| S1 | 92.96 | -15.73 | -14.47% |
| S2 | 99.46 | -9.23 | -8.49% |
| S3 | 103.23 | -5.46 | -5.02% |
| S4 | 105.96 | -2.73 | -2.51% |
UNIENTER is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 107 ~ 113.5
Trading Inside opening range
Daily traded volume and delivery percentage for Uniphos Enterprises Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Uniphos Enterprises Limited stood at 49.7% of traded volume, against a 20-day average of 63.1%.
Filings Uniphos Enterprises sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Uniphos Enterprises files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 25 documents below.
Uniphos Enterprises Limited has informed the Exchange about Copy of Newspaper Publication
Uniphos Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Nerka Chemicals Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Uniphos Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Uniphos Enterprises Limited has informed the Exchange about Copy of Newspaper Publication
Every dividend, stock split and bonus issue Uniphos Enterprises has declared, sequenced by announce and record date.
Uniphos Enterprises corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Uniphos Enterprises Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Uniphos Enterprises Limited operates in the Trading - Chemicals industry under the Chemicals sector, listed as NSE: UNIENTER, BSE: 500429.

Uniphos Enterprises Limited (UEL) is an Indian company primarily involved in the trading of chemicals and other products within the domestic market. This forms a core component of its business operations, encompassing the sourcing, distribution, and sale of a diverse range of chemical commodities. The specifics of these chemical products and their applications are not detailed in the provided information, but it's clear that chemical trading represents a significant aspect of UEL's revenue generation.
Beyond its chemical trading activities, UEL also participates in the investment sector. The company engages in investments in both listed (quoted) and unlisted (unquoted) securities. This diversification suggests a strategy aimed at balancing risk and potentially generating additional returns beyond the trading arm of the business. The nature and scale of these investments – whether in stocks, bonds, or other securities – remain unspecified in the provided context.
Established in 1969 and headquartered in Mumbai, India, UEL boasts a relatively long history in the Indian business landscape. This suggests a degree of established market presence and potentially strong relationships within the chemical and investment communities. The company's longevity might also indicate a resilient business model capable of adapting to evolving market conditions over several decades.
It's important to note that UEL operates as a subsidiary of Nerka Chemicals Private Limited. This organizational structure indicates that UEL's strategic direction and operational decisions are ultimately influenced by its parent company. The nature of the relationship between Nerka Chemicals and UEL, and the extent to which Nerka Chemicals provides resources or direction, are not detailed in the available information.
In summary, Uniphos Enterprises Limited functions as a multifaceted company operating within the chemical trading and investment sectors in India. Its long operational history and subsidiary status within a larger chemical entity provide context for understanding its position and activities within the Indian market. However, the specifics of its product range, investment portfolio, and the exact nature of its relationship with its parent company are not fully elaborated upon in the source material.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Uniphos Enterprises Limited (UNIENTER) is ₹108.69. Today, the stock has declined by ₹1.86 (1.68%), trading in a range of ₹107 to ₹113.5. The stock opened at ₹113.5 with a trading volume of 3,755 shares.
Uniphos Enterprises Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹765 crores, P/E ratio of 36.91, ROE of 0.80%, and ROCE of 0.80%. The dividend yield stands at 0.46%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Uniphos Enterprises Limited (UNIENTER) is ₹168.5, while the 52-week low is ₹87.51. Currently trading at ₹108.69, the stock is 26.2% away from its 52-week low and 35.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Uniphos Enterprises Limited stock at ₹108.69 depends on multiple factors. The stock is currently trading with a P/E ratio of 36.91 and P/B ratio of 0.31. Today's performance shows a loss of 1.68%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Uniphos Enterprises Limited offers a dividend yield of 0.46%, which means for every ₹100 invested at the current price of ₹108.69, you can expect to receive approximately ₹0.46 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Uniphos Enterprises Limited's key financial metrics include: P/E Ratio: 36.91, P/B Ratio: 0.31, ROE: 0.80%, ROCE: 0.80%, Dividend Yield: 0.46%, EPS: ₹2.98, Book Value: ₹348.1, and Debt-to-Equity: 0.00. The company's market cap stands at ₹765 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Uniphos Enterprises Limited stock opened at ₹113.5 and is currently trading at ₹108.69, showing a decline of ₹1.86 (1.68%). The intraday high is ₹113.5 and low is ₹107. The trading volume stands at 3,755 shares, indicating moderate market participation today.
Uniphos Enterprises Limited has a Price-to-Earnings (P/E) ratio of 36.91, which means investors are willing to pay ₹36.91 for every ₹1 of earnings. With an EPS of ₹2.98, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Uniphos Enterprises Limited (UNIENTER) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.